drugset / Trial / NCT05585112

Articaine 4% Versus Lidocaine 2% for Local Anesthesia of MIH-affected Maxillary Molars

NCT05585112

Phase 1/2 Completed 26 enrolled Latakia University
RandomizedCrossoverTriple-blindTreatment

Summary

Comparison of injection pain with lidocaine and articaine. Comparison of the efficacy of lidocaine and articaine during treatment of MIH- maxillary molars. Design: A randomized, controlled, crossover, Triple-blinding clinical study including twenty six cooperative children, aged 6-12years old

Timeline

Start
2022-10-17
Primary completion
2022-12-05
Completion
2022-12-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Articaine Other / unclassified 1 ml Other
Subject Articaine Other / unclassified 4 % Other
Comparator Lidocaine Other / unclassified 1 ml Other
Comparator Lidocaine Other / unclassified 2 % Other

Indications

No indication recorded.